Spanish Red Biotech Pipeline

Novo Nordisk Pharma

Somapacitan(Long-acting growth hormone)

Type: Biodrugs/ Drugs
Therapeutic area: Metabolic / Endocrinology
Indication: Growth hormone deficiency
Phase: 3Phase III in Spain, 2Phase II, 1Phase I in Spain